ReadyCell collaborates in the BioPrintIA project as a specialized partner...Read More
ReadyCell supports the pharmacological evaluation of drug candidates to minimize costs, facilitates the success rate of candidate drugs, and speeds up new drug development.
With over 10 years of experience and 200 customers in more than 20 countries around the world, ReadyCell is the leading provider of cell-based ready-to-use products. Leveraging our expertise in specific clearance, efflux and uptake transporters, ReadyCell generates quality products approved by FDA/EMA. From small molecules to protein therapeutics, ReadyCell is your one stop shop for all your in vitro DMPK needs.